Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide. NAFLD begins as a relatively benign hepatic steatosis which can evolve to non …

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent liver disorder worldwide. It
comprises a spectrum of conditions that range from steatosis to non-alcoholic …

Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent metabolic disorder with
steadily increasing incidence rates worldwide, especially in the West. There are no drugs …

As the gut microbiota continues to be implicated in an increasing number of disease
processes, a plethora of new literature surrounding its complexity and role in the …

Nonalcoholic fatty liver disease (NAFLD) has a high prevalence worldwide, but there are no
medications approved for treatment. Gut microbiota would be a novel and promising …

Background Non-alcoholic fatty liver disease (NAFLD) is characterized by triglyceride
accumulation in the hepatocytes in the absence of alcohol overconsumption, commonly …

Background: Nonalcoholic fatty liver disease (NAFLD) is the highest incidence of chronic
liver disease worldwide, seriously endangering human health, and its pathogenesis is still …

Although non-alcoholic fatty liver disease (NAFLD) is the leading aetiology of liver disorders
in the world, there is no proven treatment for NAFLD patients with normal or low BMI. The …

Context Nonalcoholic fatty liver disease (NAFLD) is a highly prevalent and underdiagnosed
comorbidity of many chronic diseases that is associated with altered intestinal bacterial …

Non‐alcoholic fatty liver disease (NAFLD) and the more severe non‐alcoholic
steatohepatitis (NASH) represent a spectrum of diseases involving hepatic fat accumulation …